Skip to main content
Top
Published in: Rheumatology International 7/2006

01-05-2006 | Original Article

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

Authors: Nuran Turkcapar, Murat Toruner, Irfan Soykan, Olcay Tiryaki Aydintug, Hulya Cetinkaya, Nursen Duzgun, Ali Ozden, Murat Duman

Published in: Rheumatology International | Issue 7/2006

Login to get access

Abstract

To determine the prevalence, clinical and radiological characteristics of spondyloarthropathy (SpA) in patients with inflammatory bowel disease (IBD), to assess the association between HLA B27 and B51 and the extraintestinal symptoms and to evaluate whether IBD is associated with Behçet’s disease (BD). One hundred and sixty-two consecutive adult patients with established diagnosis of IBD as either Crohn’s disease (CD) or ulcerative colitis (UC) were evaluated. All the patients including those previously diagnosed with or without SpA had a complete rheumatologic examination and they were evaluated according to the European Spondyloarthropathy Study Group (ESSG) criteria for SpA and The International Study Group for Behçet’s disease criteria for BD. The demographic and clinical data were recorded on a standardized form. The radiographies were obtained in all the patients and computed tomography (CT) was performed in the patients with suspected pelvic radiographies and/or low back pain in the physical examination. Radiological evaluation was made according to the Modified New York criteria. HLA B27, B51 and anti-neutrophile cytoplasmic antigen (ANCA) were searched in all the patients. Of the 162 patients with IBD (mean age 41.48±11.63 years, male 60, female 102), 78 were CD and 84 were UC. The mean of the IBD duration was 54.92±50.32 months and SpA duration was 20.63±34.37 months. The prevalence of SpA and AS in IBD was 45.7 and 9.9%, respectively. Frequencies of SpA and AS, the difference between UC and CD were not significant. Spondylitis, enthesitis, peripheral arthritis, oral ulcer and uveitis were not different between UC and CD, but erythema nodosum was found significantly more common in the CD patients compared with UC patients (P=0.005). The duration of IBD and SpA was similar in both groups. As the IBD duration increased, the prevalence of SpA development decreased (rr=0.991, P=0.009). Of the IBD patients, 13.6% were asymptomatic for musculoskeletal manifestations of SpA and their sacroiliac radiographies and CTs showed grade 2 sacroiliitis. HLA B27, B51 and ANCA positivities were not different between the patients with UC and CD. HLA B27 was significantly more common in the patients with sacroiliitis, spondylitis, enthesitis, peripheral arthritis, erythema nodosum, uveitis (P<0.001) and oral ulcer (P=0.025). BD was diagnosed in none of the patients. ANCA positivity was found to be related with the presence of erythema nodosum and uveitis (P=0.001 and P=0.005). The prevalence of SpA and AS is higher in the prospectively evaluated patients with radiological studies than those in the previously published studies. There is a high prevalence of asymptomatic sacroiliitis in IBD. An early diagnosis of inflammatory arthritis in IBD patients may prevent a disability due to SpA and AS.
Literature
1.
go back to reference Baeten D, De Keyser F, Mielants H, Veys EM (2002) Ankylosing spondylitis and bowel disease. B Pract Res Clin Rheumatol 16:537–549CrossRef Baeten D, De Keyser F, Mielants H, Veys EM (2002) Ankylosing spondylitis and bowel disease. B Pract Res Clin Rheumatol 16:537–549CrossRef
2.
go back to reference Smale S, Natt RS, Orchard TR, Russel AS, Bjarnason I (2001) Inflammatory bowel disease and spondyloarthropathy. Arthritis Rheum 44:2728–2736CrossRefPubMed Smale S, Natt RS, Orchard TR, Russel AS, Bjarnason I (2001) Inflammatory bowel disease and spondyloarthropathy. Arthritis Rheum 44:2728–2736CrossRefPubMed
3.
go back to reference Gravallese EM, Kantrowitz FG (1988) Arthritic manifestations of inflammatory bowel disease. Am J Gastroenterol 83:703–709PubMed Gravallese EM, Kantrowitz FG (1988) Arthritic manifestations of inflammatory bowel disease. Am J Gastroenterol 83:703–709PubMed
4.
go back to reference Schorr-Lesnick B, Brandt LJ (1988) Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol 83:216–223PubMed Schorr-Lesnick B, Brandt LJ (1988) Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol 83:216–223PubMed
5.
go back to reference Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136:896–907PubMed Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136:896–907PubMed
6.
7.
go back to reference Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF et al (1997) A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a community wide epidemiologic study. Has the classic case misled us? Arch Intern Med 157:2111–2117CrossRefPubMed Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF et al (1997) A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a community wide epidemiologic study. Has the classic case misled us? Arch Intern Med 157:2111–2117CrossRefPubMed
8.
go back to reference Spoorenberg A, van der Hejde D, de Klerk E, Dougados M, de Vlam K, Mielents H et al (1999) Relative values of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed Spoorenberg A, van der Hejde D, de Klerk E, Dougados M, de Vlam K, Mielents H et al (1999) Relative values of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed
9.
go back to reference Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M et al (2001) Musculoskeletal manifestation in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313CrossRefPubMed Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M et al (2001) Musculoskeletal manifestation in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313CrossRefPubMed
10.
go back to reference de Vlam K, Mielants H, Cuvelier C, de Keyser F, Veys EM, de Vos M (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860–2865PubMed de Vlam K, Mielants H, Cuvelier C, de Keyser F, Veys EM, de Vos M (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860–2865PubMed
11.
go back to reference Palm O, Moum B, Ongre A, Gran JT (2002) Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (The IBSEN Study). J Rheumatol 29:511–515PubMed Palm O, Moum B, Ongre A, Gran JT (2002) Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (The IBSEN Study). J Rheumatol 29:511–515PubMed
12.
go back to reference Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122CrossRefPubMed Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122CrossRefPubMed
13.
go back to reference Gul A, Uyar FA, Inanc M, Ocal L, Barrett JH, Aral H et al (2002) A weak association of HLA-B*2702 with Behcet’s disease. Genes Immun 3:368–372CrossRefPubMed Gul A, Uyar FA, Inanc M, Ocal L, Barrett JH, Aral H et al (2002) A weak association of HLA-B*2702 with Behcet’s disease. Genes Immun 3:368–372CrossRefPubMed
14.
go back to reference Houman H, Ben Dahmen F, Ben Ghorbel I, Chouaib S, Lamloum M, Kchir N et al (2001) Behcet’s disease associated with Crohn’s disease. Ann Med Interne (Paris) 152:480–482 Houman H, Ben Dahmen F, Ben Ghorbel I, Chouaib S, Lamloum M, Kchir N et al (2001) Behcet’s disease associated with Crohn’s disease. Ann Med Interne (Paris) 152:480–482
15.
go back to reference Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRef Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRef
16.
go back to reference van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef
17.
go back to reference International Study Group for Behçet’s Disease: criteria for diagnosis of Behçet’s disease (1990) Lancet 335:1078–1080 International Study Group for Behçet’s Disease: criteria for diagnosis of Behçet’s disease (1990) Lancet 335:1078–1080
18.
go back to reference Steer S, Jones H, Hibbert J, Kondeatis E, Vaughan R, Sanderson J et al (2003) Low back pain, sacroiliitis, and the relation with HLA-B27 in Crohn’s disease. J Rheumatol 30:518–522PubMed Steer S, Jones H, Hibbert J, Kondeatis E, Vaughan R, Sanderson J et al (2003) Low back pain, sacroiliitis, and the relation with HLA-B27 in Crohn’s disease. J Rheumatol 30:518–522PubMed
19.
go back to reference Scarpa R, Del Puente A, D’Arienzo A, di Girolamo C, della Valle G, Panarese A (1992) The arthritis of ulcerative colitis: clinical and genetical aspects. J Rheumatol 19:373–377PubMed Scarpa R, Del Puente A, D’Arienzo A, di Girolamo C, della Valle G, Panarese A (1992) The arthritis of ulcerative colitis: clinical and genetical aspects. J Rheumatol 19:373–377PubMed
20.
go back to reference Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391PubMedCrossRef Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391PubMedCrossRef
21.
go back to reference Scott WW, Fishman EK, Kuhlman JE, Caskey CI, O’Brien JJ, Walia GS et al (1990) Computed tomography evaluation of the sacroiliac joints in Crohn’s disease. Radiologic/clinical correlation. Skeleton Radiol 19:207–210 Scott WW, Fishman EK, Kuhlman JE, Caskey CI, O’Brien JJ, Walia GS et al (1990) Computed tomography evaluation of the sacroiliac joints in Crohn’s disease. Radiologic/clinical correlation. Skeleton Radiol 19:207–210
22.
go back to reference Queri R, Maiz O, Intxausti J, de Dios JR, Belzunegui J, Gonzalez C et al (2000) Subclinic sacroiliitis in inflammatory bowel disease: a clinical and follow-up study. Clin Rheumatol 19:445–449CrossRefPubMed Queri R, Maiz O, Intxausti J, de Dios JR, Belzunegui J, Gonzalez C et al (2000) Subclinic sacroiliitis in inflammatory bowel disease: a clinical and follow-up study. Clin Rheumatol 19:445–449CrossRefPubMed
23.
go back to reference McEniff N, Eustace S, McCharthy C, O’Malley M, O’Morain CA, Hamilton S (1995) Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography. Clin Imaging 19:258–262CrossRefPubMed McEniff N, Eustace S, McCharthy C, O’Malley M, O’Morain CA, Hamilton S (1995) Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography. Clin Imaging 19:258–262CrossRefPubMed
24.
go back to reference Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K (1994) High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum 37:23–31PubMedCrossRef Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K (1994) High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum 37:23–31PubMedCrossRef
25.
go back to reference Mielants H, De Vos M, Cuvelier C, Veys EM (1996) The role of gut inflammation in the pathogenesis of spondyloarthropathies. Acta Clin Belg 51:340–349PubMed Mielants H, De Vos M, Cuvelier C, Veys EM (1996) The role of gut inflammation in the pathogenesis of spondyloarthropathies. Acta Clin Belg 51:340–349PubMed
26.
go back to reference Torok HP, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H et al (2004) Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion 70:49–54CrossRefPubMed Torok HP, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H et al (2004) Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion 70:49–54CrossRefPubMed
27.
go back to reference Picco P, Gattorno M, Vignola S, Barabino A, Marazzi MG, Bondi E et al (1999) Clinical and biological characteristics of immunopathological disease-related erythema nodosum in children. Scand J Rheumatol 28:27–32CrossRefPubMed Picco P, Gattorno M, Vignola S, Barabino A, Marazzi MG, Bondi E et al (1999) Clinical and biological characteristics of immunopathological disease-related erythema nodosum in children. Scand J Rheumatol 28:27–32CrossRefPubMed
28.
go back to reference Gordon LK, Eggene M, Holland GN, Weisz JM, Braun J (1998) pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol 18:264–271CrossRefPubMed Gordon LK, Eggene M, Holland GN, Weisz JM, Braun J (1998) pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol 18:264–271CrossRefPubMed
29.
go back to reference Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapoglu E et al (2004) HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers 20:309–312PubMed Oguz FS, Ocal L, Diler AS, Ozkul H, Asicioglu F, Kasapoglu E et al (2004) HLA B-27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers 20:309–312PubMed
30.
go back to reference Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C (2004) HLA class I and II genotyping in patients with Behcet’s disease: a regional study of eastern part of Turkey. Tissue Antigens 64:293–297CrossRefPubMed Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C (2004) HLA class I and II genotyping in patients with Behcet’s disease: a regional study of eastern part of Turkey. Tissue Antigens 64:293–297CrossRefPubMed
Metadata
Title
The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease
Authors
Nuran Turkcapar
Murat Toruner
Irfan Soykan
Olcay Tiryaki Aydintug
Hulya Cetinkaya
Nursen Duzgun
Ali Ozden
Murat Duman
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0044-9

Other articles of this Issue 7/2006

Rheumatology International 7/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.